Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
|
By LabMedica International staff writers Posted on 02 Aug 2016 |

Image: The IDS-iSYS Multi-Discipline Automated System brings testing efficiency and uncompromised quality to specialty immunoassay testing in laboratories of all types and volumes (Photo courtesy of Immunodiagnostic Systems).
An automated, CE-marked diagnostic test for 17-Hydroxyprogesterone (17-OH P) is among the assays that are being demonstrated by Immunodiagnostic Systems Holdings PLC (Tyne & Wear, United Kingdom) in Booth 137 at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).
17-Hydroxyprogesterone (17-OH P) is a steroid hormone produced in both the adrenal gland and gonads, which is synthesized from either progesterone or 17-hydroxypregnenolone. It functions as a precursor of cortisol in the adrenal glands or is converted into androgenic and estrogenic hormones. Measurement of 17-OH P is used as an aid in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries.
The IDS-iSYS 17-OH Progesterone assay is an in vitro diagnostic device intended for use with the IDS-iSYS Multi-Discipline Automated System for the quantitative determination of 17-OH Progesterone in human serum or plasma.
The iSYS Multi-Discipline Automated System presents a total instrument solution based on simplicity and reliability with full walk-away automation in a compact, bench-top design. The instrument features on-board refrigeration of ready-to-use reagent cartridges, continuous loading with batch, random, and STAT flexibility with easy operation from auto start-up to shutdown.
Related Links:
Immunodiagnostic Systems
AACC Annual Meeting & Clinical Lab Expo
17-Hydroxyprogesterone (17-OH P) is a steroid hormone produced in both the adrenal gland and gonads, which is synthesized from either progesterone or 17-hydroxypregnenolone. It functions as a precursor of cortisol in the adrenal glands or is converted into androgenic and estrogenic hormones. Measurement of 17-OH P is used as an aid in the diagnosis and treatment of various disorders of the adrenal glands or the ovaries.
The IDS-iSYS 17-OH Progesterone assay is an in vitro diagnostic device intended for use with the IDS-iSYS Multi-Discipline Automated System for the quantitative determination of 17-OH Progesterone in human serum or plasma.
The iSYS Multi-Discipline Automated System presents a total instrument solution based on simplicity and reliability with full walk-away automation in a compact, bench-top design. The instrument features on-board refrigeration of ready-to-use reagent cartridges, continuous loading with batch, random, and STAT flexibility with easy operation from auto start-up to shutdown.
Related Links:
Immunodiagnostic Systems
AACC Annual Meeting & Clinical Lab Expo
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
CSF Biomarker Improves Diagnosis of Parkinson’s Disease and Lewy Body Dementia
Parkinson’s disease and dementia with Lewy bodies are frequently misdiagnosed, often being confused with Alzheimer’s disease because of overlapping symptoms. Objective diagnostics for these synucleinopathies... Read more
Simple Urine Home Test Kit Could Detect Early-Stage Breast Cancer
Breast cancer is the most commonly diagnosed cancer among women globally and remains a leading cause of cancer-related deaths in more than 100 countries. Current diagnostic pathways rely on mammography,... Read moreMolecular Diagnostics
view channel
New Respiratory Panel Expands Pathogen Detection to 25 Targets
Respiratory infections often present with overlapping symptoms, complicating differential diagnosis in acute and community settings. The stakes are higher for older adults, young children, and people with... Read more
Simple Nasal Swab May Reveal Early Signs of Alzheimer’s Disease
Alzheimer’s disease affects millions worldwide but remains difficult to detect at its earliest, pre-symptomatic stage. Clinicians need tools that can identify biological changes before cognitive symptoms... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
Early identification of treatment response and relapse remains a major challenge in solid tumors, where minimal residual disease is difficult to detect with routine imaging and blood tests.... Read moreMicrobiology
view channel
Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
Accurate and rapid identification of bacterial infections remains challenging in acute care, where delays can hinder timely, targeted therapy. Infectious diseases are a major cause of mortality worldwide,... Read more
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
Pneumonia is commonly confirmed with chest X-rays or laboratory assays that can take hours, delaying clinical decisions in acute and outpatient settings. Breath-based diagnostics promise faster answers... Read more
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more









